Mapping large numbers of results may take a few moments.
Search Results
Showing 201 - 250 of 657 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill | |
Company Denizen Biologics LLC | Activity: Research and Development | Company Description Denizen Biologics develops gene therapy vectors to enhance the capability of genetic medicine and improve the outcomes for patients. | Location Cary | |
Company Dermavant Sciences | Activity: Research and Development | Company Description Dermavant, a part of the Roivant family of companies, develops therapies for the treatment of skin diseases. | Location Morrisville | |
Company Diabetic Health Inc. | Activity: Research and Development | Company Description Diabetic Health develops coatings to improve the longevity and performance of continuous glucose monitoring sensors (CGM) and insulin infusion sets used in diabetes management. | Location Research Triangle Park | |
Company Diamond Orthopedic LLC | Activity: Production and Manufacturing | Company Description Diamond Orthopedic has developed and markets proprietary bone screw technology for orthopedic fixation. | Location Belmont | |
Company Dignify Therapeutics LLC | Activity: Research and Development | Company Description Dignify Therapeutics develops novel bowel and bladder therapies for people with neurological disorders and the elderly that suffer from incontinence. | Location Research Triangle Park | |
Company DMC Biotechnologies Inc. | Activity: Research and Development | Company Description DMC Biotechnologies sustainably produces bio-based chemicals. | Location Morrisville | |
Company DNAli Data Technologies Inc. | Activity: Research and Development | Company Description DNAli is developing and commercializing DNA-based data technologies including data storage and low-cost production of chemically tagged DNA. | Location Cary | |
Company Domus Diagnostics | Activity: Research and Development | Company Description Domus Diagnostics is a point-of-care diagnostics company that develops accurate, rapid molecular tests for infectious diseases. | Location Durham | |
Company Doron Therapeutics | Activity: Research and Development | Company Description Doron Therapeutics is developing an injectable biologic to treat osteoarthritis and other musculoskeletal diseases. | Location Chapel Hill | |
Company DotBio LLC | Activity: Research and Development | Company Description DotBio develops immuno-oncology therapies. | Location Weddington | |
Company Drive Therapeutics LLC | Activity: Research and Development | Company Description Drive Therapeutics is developing therapeutics for wet age-related macular degeneration (wAMD) and diabetic retinopathy/diabetic macular edema (DR/DME). | Location Research Triangle Park | |
Company Dualogics LLC | Activity: Research and Development | Company Description Dualogics researches and develops bispecific antibody products based on their proprietary OrthoMab platform. | Location Durham | |
Company DuraBull Pharmaceuticals Inc. | Activity: Research and Development | Company Description DuraBull Pharmaceuticals develops medical therapies for patients with hereditary aortopathy. | Location Durham | |
Company DuraVax Inc. | Activity: Research and Development | Company Description DuraVax is developing thermo-stable liquid formulations for RNA pharmaceuticals. | Location Wilmington | |
Company Eclipse Life Sciences Inc. | Activity: Research and Development | Company Description Eclipse Life Sciences is developing therapeutic compounds to treat front-of-the-eye diseases, such as uveitis and dry eye, as well as back-of-the-eye diseases, such as wet or dry macular degeneration or diabetic retinopathy. | Location Research Triangle Park | |
Company EcoClosure LLC | Activity: Research and Development | Company Description EcoClosure designs microalgae windows for building enclosures as a closed-loop regenerable technology. | Location Concord | |
Company Eldec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. | Location Durham | |
Company Eli Lilly and Company (Concord) | Activity: Production and Manufacturing | Company Description Eli Lilly will manufacture parenteral products and devices in Concord. | Location Concord | |
Company Eli Lilly and Company (Durham) | Activity: Production and Manufacturing | Company Description Lilly specializes in drug product formulation, filling and inspection of syringes and building and packaging of auto-injectors at its RTP site | Location Durham | |
Company Elo Life Systems Inc. | Activity: Research and Development | Company Description Elo Life Systems uses a platform of precision breeding technologies to produce crops with novel traits. | Location Durham | |
Company Elysia Creative Biology | Activity: Research and Development | Company Description Elysia Creative Biology has developed cattle feed that reduces methane emissions. | Location Raleigh | |
Company Emergo Therapeutics Inc. | Activity: Research and Development | Company Description Emergo Therapeutics develops drugs to reduce the production of inflammatory cytokines from mast cells and improve the functioning of the immune system in various potential indications, starting with infectious diseases. | Location Durham | |
Company Encoded Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Encoded is developing and commercializing gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. | Location Morrisville | |
Company Endacea Diagnostics Inc. | Activity: Research and Development | Company Description Endacea Diagnostics is developing EndaTox IVD, an in vitro sepsis diagnostic, and EndaTox Test, an assay to measure LPS endotoxin in biological and non-biological samples. | Location Research Triangle Park | |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park | |
Company Enfuego Therapeutics Inc. | Activity: Research and Development | Company Description Enfuego Therapeutics is developing novel RNA interference-(RNAi)-based and antisense oligo therapeutics. | Location Morrisville | |
Company Entegrion Inc. | Activity: Research and Development | Company Description Entegrion offers a novel point of care in vitro diagnostic blood coagulation monitoring system for use in human and veterinary medicine. | Location Durham | |
Company ENTEX Technologies Inc. | Activity: Research and Development | Company Description ENTEX Technologies provides advanced biological and filtration wastewater treatment that can be customized for various industries. | Location Chapel Hill | |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham | |
Company EnviroFlight LLC | Activity: Research and Development | Company Description EnviroFlight provides dried black soldier fly larvae products as a source of sustainable alternative protein. | Location Apex | |
Company Envu | Activity: Research and Development | Company Description Envu develops and markets pest-, weed- and disease-control products for non-agricultural areas such as vector control, professional pest management, industrial vegetation management, forestry and turf and ornamentals. | Location Cary | |
Company Enzerna Biosciences Inc. | Activity: Research and Development | Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. | Location Morrisville | |
Company EpiCypher Inc. | Activity: Research and Development | Company Description EpiCypher develops and manufactures novel products and services for epigenetics and chromatin biology, focused on enabling drug discovery research and development. | Location Durham | |
Company Epigenos Biosciences Inc. | Activity: Research and Development | Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage site-specific DNA binding technologies to treat disease at the root of gene mis-regulation. | Location Morrisville | |
Company Eppin Pharma Inc. | Activity: Research and Development | Company Description Eppin Pharma is developing a non-hormonal male oral contraceptive. | Location Durham | |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill | |
Company Essential Pharmaceuticals LLC | Activity: Research and Development | Company Description Essential Pharmaceuticals sells organ preservation solutions. | Location Durham | |
Company EternaTear Inc. | Activity: Research and Development | Company Description EternaTear had developed a novel artificial tear formulation that provides long lasting ocular lubrication to offer relief from dry eye. | Location Raleigh | |
Company Evecxia Inc. | Activity: Research and Development | Company Description Evecxia is developing drugs which amplify serotonin synthesis to treat neuropsychiatric conditions for which current therapies are inadequate. | Location Research Triangle Park | |
Company Exela Pharma Sciences LLC | Activity: Production and Manufacturing | Company Description Exela Pharma Sciences develops, manufactures and markets sterile injectable pharmaceuticals and provides contract manufacturing services. The Lenoir site is a cGMP-compliant sterile manufacturing facility. | Location Lenoir | |
Company Extrel Therapeutics Inc. | Activity: Research and Development | Company Description Extrel Therapeutics is developing medical devices to protect patients from post-operative infection, pain and inflammation. | Location Raleigh | |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham | |
Company Eyedesis Biosciences LLC | Activity: Research and Development | Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. | Location Chapel Hill | |
Company FafaBiotic LLC | Activity: Research and Development | Company Description Fafabiotic develops bioformulations for topical and ingestible probiotics for human health. Fafabiotic also offers consulting services on various aspects of biological product development, from feasibility and technology evaluation to scale-up and readiness for commercialization. | Location Cary | |
Company Fair Products Inc. | Activity: Production and Manufacturing | Company Description Fair Products manufactures and distributes tobacco crop care products including insecticides, sucker control, ripeners and fertilizers. | Location Cary | |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh | |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park | |
Company Fernel Therapeutics Inc. | Activity: Research and Development | Company Description Fernel Therapeutics develops medical devices and pharmaceuticals for the treatment of benign or non-infectious diseases of the pelvic region. | Location Apex | |
Company Fervent Pharmaceuticals LLC | Activity: Research and Development | Company Description Fervent Pharmaceuticals develops a nonhormonal product, FP-101, to treat vasomotor symptoms associated with menopause. | Location Greenville |